Entry Japan with Clarity, Execute with Confidence

Summary

For biopharmaceutical companies, Japan is one of the world’s most important markets, but also among the most operationally complex. Many therapies with strong global clinical validation still face significant barriers to successful market entry, not due to scientific limitations, but because regulatory strategy, operational readiness, supply planning, and commercialization are not aligned early in the process. Although regulatory planning, business operations preparation, and supply planning are closely interconnected, they are often managed separately.